Opioids and the gut: pharmacology and current clinical experience.
about
Novel pharmacology: asimadoline, a kappa-opioid agonist, and visceral sensationEvolving paradigms in the treatment of opioid-induced bowel dysfunctionA critical appraisal of lubiprostone in the treatment of chronic constipation in the elderlyConsensus Recommendations on Initiating Prescription Therapies for Opioid-Induced ConstipationThe Useage of Opioids and their Adverse Effects in Gastrointestinal Practice: A ReviewChemotherapy-Induced Constipation and Diarrhea: Pathophysiology, Current and Emerging TreatmentsOpioid-induced bowel dysfunction: prevalence, pathophysiology and burdenAcetylcholine serves as a derepressor in Loperamide-induced Opioid-Induced Bowel Dysfunction (OIBD) in zebrafishRandomized open-label phase II study comparing oxycodone-naloxone with oxycodone in early return of gastrointestinal function after laparoscopic colorectal surgery.Combined oral prolonged-release oxycodone and naloxone in opioid-induced bowel dysfunction: review of efficacy and safety data in the treatment of patients experiencing chronic pain.The analgesic efficacy of oxycodone hydrochloride versus fentanyl during outpatient artificial abortion operation: A randomized trialNovel therapeutic agents in neurogastroenterology: advances in the past year.Different effects of morphine and oxycodone in experimentally evoked hyperalgesia: a human translational study.EMERGING THERAPIES AND NOVEL APPROACHES TO VISCERAL PAIN.Long-term safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate-to-severe chronic cancer pain.Characterisation of opioid receptors involved in modulating circular and longitudinal muscle contraction in the rat ileum.Factors associated with delayed gastric emptying in patients with stent placement for malignant gastric outlet obstruction.A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate/severe, chronic cancer pain.Initial experience with ketamine-based analgesia in patients undergoing robotic radical cystectomy and diversionBezoar in a Pediatric Oncology Patient Treated with Coca-Cola.Early investigational therapeutics for gastrointestinal motility disorders: from animal studies to Phase II trials.6β-N-heterocyclic substituted naltrexamine derivative NAP as a potential lead to develop peripheral mu opioid receptor selective antagonists.Chronic methadone use, poor bowel visualization and failed colonoscopy: a preliminary study.Clinical management of pain in advanced lung cancer.The Impact of Opioid Treatment on Regional Gastrointestinal Transit.Randomized placebo-controlled study of intravenous methylnaltrexone in postoperative ileusPharmacological agents currently in clinical trials for disorders in neurogastroenterology.Pharmacological pain management in chronic pancreatitis.Translational pain research: evaluating analgesic effect in experimental visceral pain models.Assessing analgesic actions of opioids by experimental pain models in healthy volunteers - an updated review.Methylnaltrexone: a novel approach for the management of opioid-induced constipation in patients with advanced illness.Safety of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea.Critical illness, gastrointestinal complications, and medication therapy during enteral feeding in critically ill adult patients.Investigational agents for the irritable bowel syndrome.Opioid-induced constipation: challenges and therapeutic opportunities.Agents that act luminally to treat diarrhoea and constipation.Clinical and economic burden of opioid use for postsurgical pain: focus on ventilatory impairment and ileus.Methylnaltrexone for the treatment of opioid-induced constipation.Oxycodone combined with opioid receptor antagonists: efficacy and safety.Treatment with Methylnaltrexone and IVIG for Paraneoplastic Gastrointestinal Dysmotility.
P2860
Q24644669-B572D6F9-CF8D-434C-A59B-25C990419E1AQ26777692-68696F4C-16C4-4347-9B02-241BDBD95070Q26824999-A4D27314-8BCD-4F15-B8F1-30E80F60CC12Q26830397-998C0FE2-ECB5-4B33-BB8A-35D2FAA75538Q26851158-CF65028C-38B0-4375-9ADB-67264BEA04E2Q28079705-567EF7B6-C644-48FD-BFCD-C8257ADD6065Q28209970-430AAFF8-92B0-433C-A203-04582C4CB725Q30582847-0157AC6A-A4C6-4E2B-8661-BF2EBC65AF78Q33469051-D7C7EC3D-950E-4D6A-9C6A-02A72F6D45B2Q33520508-4C240488-2FE6-4181-A41F-305BAA8BED4AQ33879872-7FB6C8CF-89C0-4446-9E8B-FDEEA87B7062Q33934623-54D63A06-EACE-4573-A352-5BF8CBC745FFQ34026235-AFB4C3F2-CFF2-4B0B-93C1-560812002F62Q34485671-B9B3BF40-66FF-486C-B344-5F45369A6FE3Q35028902-80FD1424-3AD8-4519-88D0-B1D6BE96B29BQ35048680-1E28396D-D4BA-463F-8080-894D24626BC9Q35633162-38E4EA74-6EBC-4BFD-8443-521483B1FF28Q35664979-59A3F1FE-653A-4CC2-A694-258F67AE53A7Q35777579-12A7A169-C07E-4A2A-9A70-FC02DD942046Q35903163-16CE3D8E-03E0-4B60-8B35-750C037CF5BAQ36082843-B3505F9A-0A88-4E55-8B0E-71804BECEA15Q36090988-A9593553-8965-4D1E-A9D7-255A6DA1BDDEQ36215519-0778F11E-12A5-4603-9179-98573369CF13Q36327481-4448155C-8E3E-4FD3-8A0F-B70BA055DAACQ36762661-D95B71BE-6335-48D7-BDBD-62CFC904CC27Q37077184-B1771FDD-53D3-468F-9D03-B4148F136BDAQ37200907-2C5984B4-5026-4BB9-B202-C41D29E8BEF7Q37317433-3F40CCA5-CC7F-4E15-A965-EF88BF9360AFQ37365359-B5914447-4722-4D49-9BEC-A3B6261905DAQ37399423-0410557E-3022-4577-B0E8-DB284A44920BQ37611847-11F904E1-9B8D-416A-9623-790CF2B57D34Q37654528-FAD25DB7-36D3-44BA-99F3-3EB051B95495Q37686927-40D10531-1B8C-4341-8153-2BFD893354CDQ37788218-5D09B4B0-C7F6-4DD9-916B-FAAF914DB712Q37846099-A3BAAC85-0D0A-4BBD-B335-80A18F4BBB2BQ38040321-48BCCE69-01AA-4220-8C98-CDB79504F408Q38041515-343FF2F6-3AB9-45CD-97D9-4D066F568D75Q38069607-60AEE6FE-9608-4CF3-B7ED-2A70598C128BQ38093671-D648C869-B30E-4391-9457-C12273CA4DEBQ38202638-126C0522-CA5B-4E59-9E97-4675D7D257F9
P2860
Opioids and the gut: pharmacology and current clinical experience.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Opioids and the gut: pharmacology and current clinical experience.
@ast
Opioids and the gut: pharmacology and current clinical experience.
@en
type
label
Opioids and the gut: pharmacology and current clinical experience.
@ast
Opioids and the gut: pharmacology and current clinical experience.
@en
prefLabel
Opioids and the gut: pharmacology and current clinical experience.
@ast
Opioids and the gut: pharmacology and current clinical experience.
@en
P2093
P2860
P1476
Opioids and the gut: pharmacology and current clinical experience
@en
P2093
P2860
P304
P356
10.1111/J.1365-2982.2004.00513.X
P577
2004-08-01T00:00:00Z